Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure

被引：5

作者：

McClellan, MB ^{[1
]}

Loeb, JM

Clancy, CM

Francis, GS

Jacobs, AK

Kizer, KW

O'Kane, ME

Wolk, MJ

机构：

[1] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA

[2] Joint Commiss Accreditat Healthcare Org, Oak Brook Terrace, IL 60181 USA

[3] Agcy Healthcare Res & Qual, Rockville, MD 20850 USA

[4] Heart Failure Soc Amer, St Paul, MN 55114 USA

[5] Amer Heart Assoc, Dallas, TX 75231 USA

[6] Natl Qual Forum, Washington, DC 20005 USA

[7] Natl Comm Qual Assurance, Washington, DC 20036 USA

[8] Amer Coll Cardiol, Bethesda, MD 20814 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2005年 / 142卷 / 05期

关键词：

D O I：

10.7326/0003-4819-142-5-200503010-00017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：386 / 387

页数：2

共 7 条

[1]

Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002

[2] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial [J].

Granger, CB ;

McMurray, JJV ;

Yusuf, S ;

Held, P ;

Michelson, EL ;

Olofsson, B ;

Östergren, J ;

Pfeffer, MA ;

Swedberg, K .

LANCET, 2003, 362 (9386) :772-776

[3] ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the evaluation and management of heart failure) [J].

Hunt, SA ;

Baker, DW ;

Chin, MH ;

Cinquegrani, MP ;

Feldman, AM ;

Francis, GS ;

Ganiats, TG ;

Goldstein, S ;

Gregoratos, G ;

Jessup, ML ;

Noble, RJ ;

Packer, M ;

Silver, MA ;

Stevenson, LW ;

Gibbons, RJ ;

Antman, EM ;

Alpert, JS ;

Faxon, DP ;

Fuster, V ;

Gregoratos, G ;

Jacobs, AK ;

Hiratzka, LF ;

Russell, RO ;

Smith, SC .

CIRCULATION, 2001, 104 (24) :2996-3007

[4] Implications of recent clinical trials for heart failure performance measures [J].

Konstam, MA ;

Francis, GS ;

Greenberg, BH ;

Strobeck, JE ;

Packer, M ;

Adams, KF ;

Bennett, SJ ;

Bristow, MR ;

Cohn, JN ;

Colucci, WS ;

Elkayam, U ;

Krumholz, HM ;

Liu, PP ;

Mann, DL ;

Pina, IL ;

Sabbah, HN ;

Havranek, EP ;

Lindenfeld, J .

JOURNAL OF CARDIAC FAILURE, 2004, 10 (01) :4-5

[5] Meta-analysis: Angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction [J].

Lee, VC ;

Rhew, DC ;

Dylan, M ;

Badamgarav, E ;

Braunstein, GD ;

Weingarten, SR .

ANNALS OF INTERNAL MEDICINE, 2004, 141 (09) :693-704

[6]

Linfante A, 2004, CIRCULATION, V110, P664

[7] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [J].

Pfeffer, MA ;

McMurray, JJV ;

Velazquez, EJ ;

Rouleau, JL ;

Kober, L ;

Maggioni, AP ;

Solomon, SD ;

Swedberg, K ;

Van de Werf, F ;

White, H ;

Leimberger, JD ;

Henis, M ;

Edwards, S ;

Zelenkofske, S ;

Sellers, MA ;

Califf, RM ;

Aylward, P ;

Armstrong, P ;

Barvik, S ;

Belenkov, Y ;

Dalby, A ;

Diaz, R ;

Drexler, H ;

Ertl, G ;

Francis, G ;

Hampton, J ;

Harsanyi, A ;

Kvasnicka, J ;

Mareev, V ;

Marin-Neto, J ;

Murin, J ;

Myers, M ;

Nordlander, R ;

Opolski, G ;

Soler-Soler, J ;

Spac, J ;

Stefenelli, T ;

Sugrue, D ;

Van Gilst, W ;

Varshavsky, S ;

Weaver, D ;

Zannad, F ;

Aguilar, D ;

Alvarez, A ;

Al-Taweel, M ;

Anavekar, N ;

Finn, P ;

Lopez-Jimenez, F ;

Mercier, R ;

Lewis, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1893-1906

← 1 →